Answers to the CME Quiz for "Evaluation and Treatment of Dyspareunia" by John F. Steege, MD, and Denniz A. Zolnoun, MD, MPH (Obstet Gynecol 2009;113[5])

1. The embryologic anlage of the vaginal vestibule includes the:

E. Urethra and bladder

2. The main nerve supply to the vulva is via the:

A. Pudendal nerve

3. The concept of neuroplasticity suggests that painful sensations may occur from:

D. Repeated subthreshold negative stimuli

4. Vaginal lubrication in response to sexual stimulation is derived from the:

B. Vaginal epithelium

5. Myofascial abdominal wall components of dyspareunia are best demonstrated by:

D. Having the patient lift her head during examination

6. In addition to the vagina, lichen planus can also affect the:

A. Gingiva

7. Vulvar vestibulitis is currently classified as what type of disorder?

E. Neurosensory

8. Overall, approximately what percentage of women have dyspareunia at 6 months after delivery?

B. 25%

9. Retroversion of the uterus is present in approximately what percent of normal women?

C. 20%

10. When a surgical revision of the vaginal apex for deep dyspareunia following hysterectomy is performed, approximately what percentage of patients will have recurrent pain within 2-3 years of surgery?

E. 70%

ACCME Accreditation: The American College of Obstetricians and Gynecologists (ACOG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. (Continuing medical education credit for "Evaluation and Treatment of Dyspareunia" will be available through May 2012.)

AMA PRA Category 1 Credit^TM and ACOG Cognate Credit: The American College of Obstetricians and Gynecologists (ACOG) designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits^TM or up to a maximum of 2 Category 1 ACOG cognate credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Statement: Current guidelines state that continuing medical education (CME) providers must ensure that CME activities are free from the control of any commercial interest. All authors, reviewers, and contributors have disclosed to ACOG all relevant financial relationships with any commercial interests. The authors, reviewers, and contributors declare that neither they nor any business associate nor any member of their immediate families has financial interest or other relationships with any manufacturer of products or any providers of services discussed in this program. Any conflicts have been resolved through group and outside review of all content.

Return to the Obstetrics & Gynecology web site.